Houston, TX
Join us on May 20th for a comprehensive program that all life science startups can benefit from. The day will include presentations, panel discussions, networking opportunities, and office hours with the presenting organizations.
Browne Consulting will provide insights on due diligence and corporate hygiene, crucial for startup launch preparation. Wilson Sonsini will delve into IP diligence for VC investments and BioPharma partnering, focusing on patents, freedom-to-operate, and IP licensing. SVB will host a panel discussion on healthcare investments and exits, highlighting the 2023 report and offering insights into the 2024 investment outlook, particularly in therapeutics.
Katie Stonum
kstonum@wsgr.comDr. Laurie McNamara is a partner in the patents and innovations counseling practice of Wilson Sonsini Goodrich & Rosati. Based in the firm's San Diego office, she focuses her practice on various aspects of intellectual property law for clients in the pharmaceutical and biotechnology industries. She provides strategic counseling for clients related to patent prosecution, diligence, freedom to operate, patentability, invalidity, and non-infringement analyses. She has counseled clients in a variety of IP areas, including antibodies, small molecule pharmaceuticals, proteomics, and CRISPR technologies.
J. Matthew (Matt) Lyons is a corporate partner in the Austin office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the representation of companies and their investors in the emerging companies ecosystem. For the past 25 years, he has been a leading attorney in the Texas market, advising public and private companies, venture and private equity funds, and entrepreneurs on new entity formation, venture financings, public and private offerings, mergers, acquisitions and divestitures, and issues related to corporate governance and executive compensation. Matt’s clients include companies in the technology, life sciences, healthcare, retail and CPG, and media and communications industries.